PCIのための虚血評価 非侵襲的虚血評価スタンダードマニュアル

出版社: メジカルビュー社
著者:
発行日: 2020-03-10
分野: 臨床医学:内科  >  循環器一般
ISBN: 9784758319652
電子書籍版: 2020-03-10 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

8,250 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,250 円(税込)

商品紹介

非侵襲的虚血評価のすべてがわかる,慢性冠動脈疾患の治療のためのPCI術者必携の一冊!
PCIの適応が考えられる病変(慢性冠動脈疾患)に対する非侵襲的虚血評価法を1冊にまとめた書籍。各々の検査法を解説するだけでなく,モダリティごとのさまざまな違いをPCIによる治療にどう活かし使い分けをするか(虚血評価をマルチモダリティでどう行うか)を実践的に解説。また,2019年3月に改訂された慢性冠動脈疾患診断ガイドラインの概説も掲載。

目次

  • I 基礎編 非侵襲的虚血評価を知る
     ■心筋シンチグラムを知る
      PCIのための心筋シンチグラムのポイント
      心筋シンチグラムの検査概要
      心筋シンチグラムの特徴
      心電図同期シンチグラム 
      J-ACCESSからみた心筋SPECTのエビデンス
      心臓専用半導体SPECT装置
     ■負荷心電図を知る
      PCIのための負荷心電図のポイント
      負荷心電図の検査概要
      負荷心電図の判読
     ■負荷心エコーを知る
      PCIのための負荷心エコー法のポイント
      負荷心エコーによる冠血流予備能評価
     ■心臓CTを知る
      PCIのための冠動脈CTのポイント
      慢性冠動脈疾患診断における冠動脈CTの有用性
      冠動脈CTの検査概要
      負荷パーフュージョン
      FFR-CTによる虚血診断とPCI
      心臓CTのエビデンスを知る
     ■心臓MRIを知る
      PCIのためのMRA
      
    II 実践編 非侵襲的虚血評価をどう使い分けるか
     ■総論
      各虚血評価法の使い分けを知る:負荷心電図,エコー,CT,シンチ,MRIの選択法
     ■心筋シンチグラム
      心筋シンチグラム:冠動脈枝別の虚血心筋のパターン
      心筋シンチグラムのピットフォール
      陳旧性心筋梗塞症における心筋バイアビリティ評価
      心筋シンチグラム:アーチファクトの見分け方
     ■負荷心電図
      負荷心電図が特に有用な患者群と症例(ガイドラインを含めて)
      負荷心電図のピットフォール
     ■負荷心エコー
      負荷心エコー法が特に有用な患者群と症例
      陳旧性心筋梗塞症における心筋バイアビリティ評価
     ■心臓CT
      冠動脈CTが特に有用な患者群と症例:
       中等度検査前確率群におけるCTの有用性(ACSの予測を含めて)
      冠動脈CTのピットフォールと成功のコツ:
       PCIに至るまでにどのように冠動脈CTを利用するか
      冠動脈CTと心筋シンチグラムのフュージョンイメージング

    III 症例解説 知っておきたい まれな症例
     症例解説 PCIせず至適内科療法が奏功した例
     症例解説 心筋バイアビリティなしと評価された症例に対するPCI
     症例解説 心筋バイアビリティ評価にPET検査が有用だった例
     症例解説 D-SPECTとMFR
     症例解説 Invasive FFRとシンチグラムの不一致例の解釈
     症例解説 冠動脈バイパスグラフトが開存しているにもかかわらず
           負荷シンチグラムで心筋虚血が認められた症例
     症例解説 CT-FFRでは診断が困難な有意狭窄病変
     症例解説 COPD,気管支喘息合併例での心筋虚血の評価
     症例解説 ドブタミン負荷心筋シンチグラムが有用だった症例

    IV ガイドライン概説
     慢性冠動脈疾患診断ガイドライン(2018年改訂版)概説

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 基礎編 非侵襲的虚血評価を知る

P.8 掲載の参考文献
1) Gould KL, Lipscomb K, Hamilton GW:Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33:87-94, 1974.
2) Falk E, Shah PK, Fuster V:Coronary plaque disruption. Circulation 92:657-671, 1995.
3) Ambrose JA, Tannenbaum MA, Alexopoulos D, et al:Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56-62, 1988.
4) Naya M, Tamaki N, Tsutsui H:Coronary flow reserve estimated by positron emission tomography to diagnose significant coronary artery disease and predict cardiac events. Circ J 79:15-23, 2015.
5) Shah PK:Plaque size, vessel size and plaque vulnerability:bigger may not be better. J Am Coll Cardiol 32:663-664, 1998.
6) Narula J, Nakano M, Virmani R, et al:Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol 61:1041-1051, 2013.
7) Lee JM, Choi G, Koo BK, et al:Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. JACC Cardiovasc Imaging 12:1032-1043, 2019.
8) Knuuti J, Wijns W, Saraste A, et al:2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J:41:407-477, 2020.
10) Nanasato M, Matsumoto N, Nakajima K, et al:Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease:J-ACCESS 4 study. Int J Cardiol 267:202-207, 2018.
11) Hori Y, Yoda S, Nakanishi K, et al:Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease. J Cardiol 65:278-284, 2015.
13) Sedlis SP, Hartigan PM, Teo KK, et al:Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N Engl J Med 373:1937-1946, 2015.
P.15 掲載の参考文献
1) Klein R, Beanlands RS, deKemp RA:Quantification of myocardial blood flow and flow reserve:Technical aspects. J Nucl Cardiol 17:555-570, 2010.
2) Verberbe HJ, Hesse B:EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT. http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf
3) Shanoudy H, Raggi P, Beller GA, et al:Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. J Am Coll Cardiol 31:331-337, 1998.
4) Henzlova MJ, Duvall WL, Einstein AJ, et al:ASNC imaging guidelines for SPECT nuclear cardiology procedures:Stress, protocols, and tracers. J Nucl Cardiol 3:606-639, 2016. https://www.asnc.org/files/Guidelines%20and%20Quality/ASNC%20SPECT%20ProtocolsTracers%20Guidelines2016.pdf
5) Leppo JA:Comparison od stressagents. J Nucl Cardiol 3:S22-S26, 1996.
6) Jain M, Nkonde C, Lin BA, et al:85% of maximal age-adjusted heart rate is not a valid endpoint for exercise treadmill testing. J Nucl Cardiol 18:1026-1035, 2011.
7) Varma SK, Watson DD, Beller G:Quantitative comparison of thallium-201 scintigraphy after exercise and ddipyridamole in coronary artery disease. Am J Cardiol 64:871-877, 1989.
8) 坂田泰史, 西村恒彦, 山崎純一, ほか:SUNY4001(アデノシン)負荷201Tlシンチグラフィの虚血検出に関する検討-労作性狭心症を対象とした第II相試験-. 核医学 41:123-132, 2004.
9) Nishimura S, Mahmarian JJ, Boyce TM, Verani MS:Equivalence between adenosine and exercise thallium-201 myocardial tomography:a multicenter, prospective, crossover trial. J Am Coll Cardiol 20:265-275, 1992.
10) 西村重敬, 西村恒彦, 山崎純一, ほか:201Tl 心筋シンチグラフィにおけるSUNY4001負荷法の臨床第III相試験-運動負荷法とクロスオーバーによる比較-. 核医学 41:143-154, 2004.
11) Karamitsos TD, Ntusi NA, Francis JM, et al:Feasibility and safety of high-dose adenosine perfusion cardi ovascular magnetic resonance. J Cardiovasc Magn Reson 12:66, 2004.
12) Djordjevic AD, Ostojic MC, Beleslin BD, et al:High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. J Am Coll Cardiol 28:1689-1695, 1996.
13) Segall GM, Davis MJ:Prone versus supine thallium myocardial SPECT:a method to decrease artifactual inferior wall defects. J Nucl Med 30:548-555, 1989.
P.23 掲載の参考文献
1) Berman DS, Abidov A, Kang X, et al:Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 11:414-423, 2004.
2) Slomka PJ, Nishina H, Berman DS, et al:Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 12:66-77, 2005.
3) Berman DS, Kang X, Gransar H, et al:Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol 16:45-53, 2009.
4) Nakajima K, Slomka P, Germano G, et al:The importance of population-specific normal database for quantification of myocardial ischemia:comparison between Japanese 360 and 180-degree databases and a US database. J Nucl Cardiol 16:422-430, 2009.
5) Yoda S, Matsumoto N, Hirayama A, et al:Validation of automated quantification of nuclear cardiology in Japanese patients using total perfusion deficits:comparison with visual assessment. J Cardiol 63:350-357, 2014.
6) Shaw LJ, Berman DS, Hartigan PM, et al:Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden:results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283-1291, 2008.
7) Yoda S, Matsumoto N, Hirayama A, et al:Diagnostic value of automated quantification of nuclear cardiology in Japanese patients with single vessel coronary artery disease:Comparison between Japanese and American normal databases. J Cardiol 62:224-229, 2013.
9) Yoda S, Matsumoto N, Hirayama A, et al:Usefulness of automated assessment of nuclear cardiology for prediction of major cardiac events in Japanese patients with known or suspected coronary artery disease:Comparison with conventional visual assessment in a large-scale prognostic study. J Cardiol 64:395-400, 2014.
10) Hachamovitch R, Hayes SW, Berman DS, et al:Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-2906, 2003.
11) Yoda S, Hori Y, Hayase M, et al:Correlation between early revascularization and major cardiac events demonstrated by ischemic myocardium in Japanese patients with stable coronary artery disease. J Cardiol 71:44-51, 2018.
12) Hori Y, Yoda S, Hirayama A, et al:Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease. J Cardiol 65:278-284, 2015.
13) Nanasato M, Matsumoto N, Nakajima K, et al:Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease:J-ACCESS 4 study. Int J Cardiol 267:202-207, 2018.
P.30 掲載の参考文献
1) Germano G, Berman DS:Clinical gated cardiac SPECT (2nd ed). Wiley-Blackwell, Malden, MA, USA, 2007, p101-102.
2) Nakajima K:Normal values for nuclear cardiology:Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 24:125-135, 2010.
3) Nakajima K, Kumita S, Ishida Y, et al:Creation and characterization of Japanese standards for myocardial perfusion SPECT:database from the Japanese Society of Nuclear Medicine Working Group. Ann Nucl Med 21:505-511, 2007.
4) Nakajima K, Matsumoto N, Kasai T, et al:Normal values and standardization of parameters in nuclear cardiology:Japanese Society of Nuclear Medicine working group database. Ann Nucl Med 30:188-199, 2016.
P.39 掲載の参考文献
1) Nishimura T, Nakajima K, Kusuoka H, et al:Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT:J-ACCESS study. Eur J Nucl Med Mol Imaging 35:319-328, 2008.
2) Yamasaki Y, Nakajima K, Kusuoka H, et al:Prognostic value of gated myocardial perfusion imaging for asymptomatic patients with type 2 diabetes:the J-ACCESS 2 investigation. Diabetes Care 33:2320-2326, 2010.
3) Nakamura S, Kawano Y, Nakajima K, et al:Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging:Final 3-year report of the J-ACCESS 3 study. J Nucl Cardiol 26:431-440, 2019.
4) Nanasato M, Matsumoto N, Nakajima K, et al:Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease:J-ACCESS 4 study. Int J Cardiol 267:202-207, 2018.
5) Nakajima K, Matsuo S, Okuyama C, et al:Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease. Circ J 76:168-175, 2012.
P.47 掲載の参考文献
1) Nakazato R, Tamarappoo BK, Kang X, et al:Quantitative upright-supine high-speed SPECT myocardial perfusion imaging for detection of coronary artery disease:correlation with invasive coronary angiography. J Nucl Med 51:1724-1731, 2010.
2) Matsumoto N, Sato Y, Suzuki Y, et al:Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in a Japanese population:a middle-term follow-up study. Circ J 71:1580-1585, 2007.
3) Matsumoto N, Sato Y, Suzuki Y, et al:Incremental prognostic value of cardiac function assessed by ECG-gated myocardial perfusion SPECT for the prediction of future acute coronary syndrome. Circ J 72:2035-2039, 2008.
4) Nakazato R, Berman DS, Gransar H, et al:Prognostic value of quantitative high-speed myocardial perfusion imaging. J Nucl Cardiol 19:1113-1123, 2012.
5) Makita A, Matsumoto N, Suzuki Y, et al:Clinical feasibility of simultaneous acquisition rest 99mTc/stress 201Tl dual-isotope myocardial perfusion single-photon emission computed tomography with semiconductor camera. Circ J 80:689-695, 2016.
6) Ben-Haim S, Murthy VL, Breault C, et al:Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans:A Feasibility Study. J Nucl Med 54:873-879, 2013.
7) Agostini D, Roule V, Nganoa C, et al:First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera:head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging 45:1079-1090, 2018.
P.50 掲載の参考文献
1) Saraste A, Kajander S, Han C, et al:PET:Is myocardial flow quantification a clinical reality? J Nucl Cardiol 19:1044-1059, 2012.
2) Di Carli MF, Charytan D, McMahon GT, et al:Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med 52:1369-1377, 2011.
3) Alexanderson E, Garcia-Rojas L, Jimenez M, et al:Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients:assessment by 13N-ammonia positron emission tomography. J Nucl Cardiol 17:1015-1022, 2010.
4) Farhad H, Dunet V, Bachelard K, et al:Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J Cardiovasc Imaging 14:1203-1210, 2013.
5) Ziadi MC, Dekemp RA, Williams KA, et al:Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 58:740-748, 2011.
6) Herzog BA, Husmann L, Valenta I, et al:Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150-156, 2009.
P.54 掲載の参考文献
1) Einstein AJ, Pascual TN, Mercuri M, et al:Current worldwide nuclear cardiology practices and radiation exposure:results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS). Eur Heart J 36:1689-1696, 2015.
2) Taillefer R, DePuey EG, Udelson JE, et al:Comparative Diagnostic Accuracy of Tl-201 and Tc-99m Sestamibi SPECT Imaging (Perfusion and ECG-Gated SPECT) in Detecting Coronary Artery Disease in Women. J Am Coll Cardiol 29:69-77, 1997.
3) 片渕哲郎, 工藤崇, 鈴木康裕, ほか:心臓核医学検査に伴う医療被曝の最適化に関するワーキンググループ報告. 日本心臓核医学会誌 21:28-31, 2019.
4) Ueyama T, Takehana K, Maeba H, Iwasaka T:Prognostic value of normal stress-only technetium-99m myocardial perfusion imaging protocol. Comparison with standard stress-rest protocol. Circ J 76:2386-2391, 2012.
P.58 掲載の参考文献
1) Cerqueira MD, Weissman NJ, Dilsizian V, et al:Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542, 2002.
P.66 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) Gibbons RJ, Balady GJ, Bricker JT, et al:ACC/AHA 2002 Guideline Update for Exercise Testing:Summary Article. Circulation 106:1883-1892, 2002.
3) Korzick DH, Underwood DA, Simpfendorfer CC:Early exercise testing following percutaneous transluminal coronary angioplasty. Cleve Clin J Med 57:53-56, 1990.
4) Borg GA:Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 14:377-381, 1982.
5) 国立循環器病研究センターほか:循環器疾患診療実態調査報告書(2017年度実施・公表). 2018. http://www.j-circ.or.jp/jittai_chosa/jittai_chosa2016web.pdf
P.73 掲載の参考文献
1) 高橋哲也, 伊東春樹, 小山照幸, ほか:診療報酬対策アンケート調査について「運動負荷試験に関するアンケート調査」. 心臓リハビリテーション 13:195-198, 2008.
2) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
3) Tanaka T, Monahan KD, Seals DR:Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37:153-156, 2001.
4) Shaw LJ, Peterson ED, Shaw LK, et al:Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 98:1622-1630, 1998.
P.81 掲載の参考文献
1) 日本循環器学会ほか:慢性虚血性心疾患の診断と病態把握のための検査法の選択基準に関するガイドライン(2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010_yamagishi_h.pdf
2) Guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommitte on Exercise Testing). J Am Coll Cardiol 8:725-738, 1986.
3) Azarbal B, Hayes SW, Lewin HC, et al:The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality:superiority over 85% of maximal agepredicted heart rate. J Am Coll Cardiol 44:423-7430, 2004.
4) Cole CR, Blackstone EH, Pashkow FJ, et al:Heart-rate recovery immediately after exercise as a predictor of mortality. N Eng J Med 341:1351-1357, 1999.
5) 疋田浩之:運動誘発性冠攣縮性狭心症. 別冊日本臨牀 循環器症候群 (第2版) II. 日本臨牀社, 大阪, 2007, p20-23.
P.83 掲載の参考文献
1) Gould KL, Lipscomb K, Hamilton GW:Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 33:87-94, 1974.
2) Nesto RW, Kowalchuk GJ:The ischemic cascade:temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 59:23C-30C, 1987.
3) Dilsizian V, Bateman TM, Bergmann SR, et al:Metabolic imaging with beta-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 112:2169-2174, 2005.
4) Ishii K, Miwa K, Makita T, Okuda N:Prolonged postischemic regional left ventricular delayed relaxation or diastolic asynchrony detected by color kinesis following coronary vasospasm. Am J Cardiol 91:1366-1369, 2003.
5) Ishii K, Imai M, Suyama T, et al:Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning:is it a reliable marker in detecting coronary artery disease? J Am Coll Cardiol 53:698-705, 2009.
6) Majmudar MD, Nahrendorf M:Cardiovascular molecular imaging:the road ahead. J Nucl Med 53:673-676, 2012.
P.91 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) Suzuki K, Hirano Y, Yamada H, et al:Practical guidance for the implementation of stress echocardiography. J Echocardiogr 16:105-129, 2018.
3) Heijenbrok-Kal MH, Fleischmann KE, Hunink MG:Stress echocardiography, stress single-photonemission computed tomography and electron beam computed tomography for the assessment of coronary artery disease:a meta-analysis of diagnostic performance. Am Heart J 154:415-423, 2007.
4) Monin JL, Quere JP, Monchi M, et al:Low-gradient aortic stenosis:operative risk stratification and predictors for long-term outcome:a multicenter study using dobutamine stress hemodynamics. Circulation 103:319-324, 2003.
5) Elhendy A, Mahoney DW, Burger KN, et al:Prognostic value of exercise echocardiography in patients with classic angina pectoris. Am J Cardiol 94:559-563, 2004.
P.100 掲載の参考文献
1) Gould KL, Lipscomb K:Effect of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34:38-55, 1974.
2) Hozumi T, Yoshida K, Akasaka T, et al:Noninvasive assessment of coronary flow velocity and coronary velocity reserve in the left anterior descending coronary artery by Doppler echocardiography:Comparison with invasive technique. J Am Coll Cardiol 32:1251-1259, 1998.
3) Fusejima K:Noninvasive measurement of coronary artery blood flow using combined twodimensional and Doppler echocardiography. J Am Coll Cardiol 10:1024-1031, 1987.
4) Daimon M, Watanabe H, Yamagishi H, et al:Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography:Comparison with exercise 201-Tl single photon emission computed tomography. J Am Coll Cardiol 37:1310-1315, 2001.
5) Tokai K, Watanabe H, Hirata K, et al:Noninvasive assessment of myocardial ischemia in the left ventricular inferior regions by coronary flow reserve measurement using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 16:1252-1257, 2003.
P.103 掲載の参考文献
1) Heijenbrok-Kal MH, Fleischmann KE, Hunink MG:Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease:a metaanalysis of 29 diagnostic performance. Am Heart J 154:415-423, 2007.
2) Dagianti A, Penco M, Agati L, et al:Stress echocardiography:comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 26:18-25, 1995.
3) Voigt JU, Exner B, Schmiedehausen K, et al:Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 107:2120-2126, 2003.
4) Onishi T, Uematsu M, Watanabe T, et al:Objective Interpretation of Dobutamine Stress Echocardiography by Diastolic Dyssynchrony Imaging:A Practical Approach. J Am Soc Echocardiogr 23:1103-1108, 2010.
5) lshii, K, Imai M, Suyama T, et al:Exercise induced post ischemic left ventricular delayed relaxation or diastolic stunning:is it a reliable marker in detecting coronary artery disease? J Am Coll Cardiol 53:698-705, 2009.
P.105 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) Roushdy A, Abou ESY, Abd EM, et al:The additional utility of two-dimensional strain in detection of coronary artery disease presence and localization in patients undergoing dobutamine stress echocardiogram. Echocardiography 34:1010-1019, 2017.
3) Joyce E, Hoogslag GE, Al Amri I, et al:Quantitative Dobutamine Stress Echocardiography Using Speckle-Tracking Analysis versus Conventional Visual Analysis for Detection of Significant Coronary Artery Disease after STSegment Elevation Myocardial Infarction. J Am Soc Echocardiogr 28:1379-1389, 2015.
4) Voigt JU, Exner B, Schmiedehausen K, et al:Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 107:2120-2126, 2003.
P.113 掲載の参考文献
1) Budoff MJ, Dowe D, Jollis JG, et al:Diagnostic Performance of 64-Multidetector Row Coronary Computed Tomography Angiography for Evaluation of Coronary Artery Stenosis in Individuals Without Known Coronary Artery Disease. JACC 52:1724-1732, 2008.
2) Miller JM, Rochitte CE, Dewey M, et al:Diagnostic Performance of Coronary Angiography by 64-Row CT. NEJM 359:2324-2336, 2008.
3) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
4) Douglas PS, Hoffmann U, Patal MR, et al:Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease. NEJM 372:1291-1300, 2015.
5) Newby DE, Adamson PD, Berry C, et al:Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. NEJM 379:924-933, 2018.
6) Cury RC, Abbara S, Achenbach S, et al:CAD-RADS(TM) Coronary Artery Disease - Reporting and Date System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10:269-281, 2016.
7) Takagi H, Tanaka R, Nagata K, et al:Diagnostic performance of coronary CT angiography with ultra-high-resolution CT;Comparison with invasive coronary angiography. European Journal of Radiology 101:30-37, 2018.
8) Schuijf JD, Wijns W, Jukema W, et al:Relationship Between Noninvasive Coronary Angiography With Multi-Slice Computed Tomography and Myocardial Perfusion Imaging. JACC 48:2508-2514, 2006.
9) Tonino PA, De Bruyne B, Pijls NH, et al:Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. NEJM 360:213-224, 2009.
10) Sekimoto T, Akutsu Y, Hamazaki Y, et al:Regional calcified plaque score evaluated by multidetector computed tomography for predicting the addition of rotational atherectomy during percutaneous coronary intervention. J Cardiovasc Comput Tomogr 10:221-228, 2016.
11) Kodama T, Kondo T, Oida A, et al:Computed Tomographic Angiography-Verified Plaque Characteristics and Slow-Flow Phenomenon During Percutaneous Coronary Intervention. JACC Cardiovasc Interv 5:636-643, 2012.
12) Okutsu M, Horio T, Tanaka H, et al:Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease. Heart and Vessels 33:1121-1128, 2018.
13) Morino Y, Abe M, Morimoto T, et al:Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes. JACC Cardiovasc Interv 4:213-221, 2011.
14) Fujino A, Otsuji S, Hasegawa M, et al:Accuracy of J-CTO Score Derived From Computed Tomography Versus Angiography to Predict Successful Percutaneous Coronary Intervention. JACC Cardiovasc Interv 11:209-217, 2018.
15) Rolf A, Werner GS, Schuhback A, et al:Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion. Int J Cardiovasc Imaging 29:1819-1827, 2013.
P.129 掲載の参考文献
1) Douglas PS, Hoffmann U, Patel MR, et al:Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372:1291-1300, 2015.
2) SCOT-HEART investigators:CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART):an open-label, parallel-group, multicentre trial. Lancet 385:2383-2391, 2015.
3) Conte E, Sonck J, Mushtaq S, et al:FFRCT and CT perfusion:A review on the evaluation of functional impact of coronary artery stenosis by cardiac CT. Int J Cardiol. pii:S0167-5273(19)30012-9, (Epub ahead of print), 2019.
4) Celeng C, Leiner T, Maurovich-Horvat P, et al:Anatomical and functional computed tomography for diagnosing hemodynamically significant coronary artery disease:a meta-analysis. JACC Cardiovasc Imaging 12:1316-1325, 2019.
5) Rochitte CE, George RT, Chen MY, et al:Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography:the CORE320 study. Eur Heart J 35:1120-1130, 2014.
6) Takx RA, Blomberg BA, El Aidi H, et al:Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging 8:2015. pii:e002666.
7) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
8) Techasith T, Cury RC:Stress myocardial CT perfusion:an update and future perspective. JACC Cardiovasc Imaging 4:905-916, 2011.
9) Nakamura S, Kitagawa K, Goto Y, et al:Incremental Prognostic Value of Myocardial Blood Flow Quantified With Stress Dynamic Computed Tomography Perfusion Imaging 12:1379-1387, 2019.
10) Lubbers M, Coenen A, Kofflard M, et al:Comprehensive Cardiac CT With Myocardial Perfusion Imaging Versus Functional Testing in Suspected Coronary Artery Disease:The Multicenter, Randomized CRESCENT-II Trial. JACC Cardiovasc Imaging 11:1625-1636, 2018.
11) van Assen M, De Cecco CN, Eid M, et al:Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease. J Cardiovasc Comput Tomogr13:26-33, 2019.
12) Kuwahara N, Tanabe Y, Kido T, et al:Coronary artery stenosis-related perfusion ratio using dynamic computed tomography myocardial perfusion imaging:a pilot for identification of hemodynamically significant coronary artery disease. Cardiovasc Interv Ther. doi:10.1007/s12928-019-00627-4, (Epub ahead of print), 2019.
P.138 掲載の参考文献
8) Norgaard BL, Gaur S, Leipsic J, et al:Influence of Coronary Calcification on the Diagnostic Performance of CT Angiography Derived FFR in Coronary Artery Disease:A Substudy of the NXT Trial. JACC Cardiovasc Imaging 2015.
9) Uzu K, Otake H, Choi G, et al:Lumen Boundaries Extracted from Coronary Computed Tomography Angiography on Computed Fractional Flow Reserve (FFRCT):Validation with Optical Coherence Tomography. EuroIntervention 2018.
10) Ko BS, Cameron JD, Munnur RK, et al:Noninvasive CT-Derived FFR Based on Structural and Fluid Analysis:A Comparison With Invasive FFR for Detection of Functionally Significant Stenosis. JACC Cardiovasc Imaging 10:663-673, 2017.
11) Fujimoto S, Kawasaki T, Kumamaru KK, et al:Diagnostic performance of on-site computed CTfractional flow reserve based on fluid structure interactions:comparison with invasive fractional flow reserve and instantaneous wave-free ratio. Eur Heart J Cardiovasc Imaging 20:343-352, 2019.
12) Douglas PS, Pontone G, Hlatky MA, et al:Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease:the prospective longitudinal trial of FFR (CT):outcome and resource impacts study. Eur Heart J:3359-3367, 2015.
13) Douglas PS, De Bruyne B, Pontone G, et al:1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease:The PLATFORM Study. J Am Coll Cardiol 68:435-445, 2016.
14) Tanaka H, Chikamori T, Tanaka N, et al:Diagnostic performance of a novel cadmium-zinctelluride gamma camera system assessed using fractional flow reserve. Circ J 78:2727-2734, 2014.
15) Hlatky MA, Saxena A, Koo BK, et al:Projected costs and consequences of computed tomographydetermined fractional flow reserve. Clin Cardiol 36:743-748, 2013.
P.150 掲載の参考文献
1) Budoff MJ, Dowe D, Jollis JG, et al:Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease:results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 52:1724-1732, 2008.
2) Miller JM, Rochitte CE, Dewey M, et al:Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 359:2324-2336, 2008.
3) Min JK, Dunning A, Lin FY, et al:Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes:An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 58:849-860, 2011.
4) Douglas PS, Hoffmann U, Patel MR, et al:Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372:1291-1300, 2015.
5) SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART):an open-label, parallel-group, multicentre trial. Lancet 385:2383-2391, 2015.
6) SCOT-HEART Investigators, Newby DE, Adamson PD, et al:Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med 379:924-933, 2018.
7) Cury RC, Abbara S, Achenbach S, et al:CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10:269-281, 2016.
8) Xie JX, Cury RC, Leipsic J, et al:The Coronary Artery Disease-Reporting and Data System (CAD-RADS):Prognostic and Clinical Implications Associated With Standardized Coronary Computed Tomography Angiography Reporting. JACC Cardiovasc Imaging 11:78-89, 2018.
9) Cury RC, Abbara S, Achenbach S, et al:CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10:269-281, 2016.
10) Hoffmann U, Truong QA, Schoenfeld DA, et al:Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 367:299-308, 2012.
11) Puchner SB, Liu T, Mayrhofer T, et al:High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain:results from the ROMICAT-II trial. J Am Coll Cardiol 64:684-692, 2014.
12) Tonino PA, De Bruyne B, Pijls NH, et al:Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213-224, 2009.
13) De Bruyne B, Fearon WF, Pijls NH, et al:Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371:1208-1217, 2014.
15) Min JK, Leipsic J, Pencina MJ, et al:Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 308:1237-1245, 2012.
16) Norgaard BL, Leipsic J, Gaur S, et al:Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease:the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography:Next Steps). J Am Coll Cardiol 63:1145-1155, 2014.
18) Fairbairn TA, Nieman K, Akasaka T, et al:Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve:lessons from the ADVANCE Registry. Eur Heart J 39:3701-3711, 2018.
19) Patel MR, Norgaard BL, Fairbairn TA, et al:1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT:The ADVANCE Registry. JACC Cardiovascular Imaging. 2019 Mar 17. pii:S1936-878X(19)30227-X. doi:10.1016/j.jcmg.2019.03.003. [Epub ahead of print]
20) Pontone G, Andreini D, Guaricci AIIncremental, et al:Diagnostic Value of Stress Computed Tomography Myocardial Perfusion With Whole-Heart Coverage CT Scanner in Intermediateto High-Risk Symptomatic Patients Suspected of Coronary Artery Disease. JACC Cardiovasc Imaging 12:338-349, 2019.
21) Rochitte CE, George RT, Chen MY, et al:Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography:the CORE320 study. Eur Heart J 35:1120-1130, 2014.
22) Lubbers M, Coenen A, Kofflard M, et al:Comprehensive Cardiac CT With Myocardial Perfusion Imaging Versus Functional Testing in Suspected Coronary Artery Disease:The Multicenter, Randomized CRESCENT-II Trial. JACC Cardiovasc Imaging 11:1625-1636, 2018.
P.159 掲載の参考文献
1) Kato S, Kitagawa K, Ishida N, et al:Assessment of coronary artery disease using magnetic resonance coronary angiography:a national multicenter trial. J Am Coll Cardiol 56:983-991, 2010.
2) Di Leo G, Fisci E, Secchi F, et al:Diagnostic accuracy of magnetic resonance angiography for detection of coronary artery disease:a systematic review and meta-analysis. Eur Radiol 26:3706-3718, 2016.
3) 日本循環器学会 ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://wwwj-circorjp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf (2019年12月閲覧).
4) Xie Y, Kim YJ, Pang J, et al:Coronary Atherosclerosis T1-Weighed Characterization With Integrated Anatomical Reference:Comparison With High-Risk Plaque Features Detected by Invasive Coronary Imaging. JACC Cardiovasc Imaging 10:637-648, 2017.
5) Moody AR, Murphy RE, Morgan PS, et al:Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107:3047-3052, 2003.
6) Kawasaki T, Koga S, Koga N, et al:Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging:comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc Imaging 2:720-728, 2009.
7) Kanaya T, Noguchi T, Otsuka F, et al:Optical coherence tomography-verified morphological correlates of high-intensity coronary plaques on non-contrast T1-weighted magnetic resonance imaging in patients with stable coronary artery disease. European heart journal cardiovascular Imaging 20:75-83, 2019.
8) Jansen CH, Perera D, Makowski MR, et al:Detection of intracoronary thrombus by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 124:416-424, 2011.
9) Noguchi T, Kawasaki T, Tanaka A, et al:High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol 63:989-999, 2014.
10) Noguchi T, Tanaka A, Kawasaki T, et al:Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging:The AQUAMARINE Pilot Study. J Am Coll Cardiol 66:245-226, 2015.
11) Asaumi Y, Noguchi T, Morita Y, et al:High-Intensity Plaques on Noncontrast T1-Weighted Imaging as a Predictor of Periprocedural Myocardial Injury. JACC Cardiovasc Imaging 8:741-743, 2015.
P.161 掲載の参考文献
2) Gargiulo P, Dellegrottaglie S, Bruzzese D, et al:The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease:a meta-analysis. Circ Cardiovasc Imaging 6:574-582, 2013.
3) Ko SM, Hwang HK, Kim SM, Cho IH:Multi-modality imaging for the assessment of myocardial perfusion with emphasis on stress perfusion CT and MR imaging. Int J Cardiovasc Imaging 31(Suppl)1:1-21, 2015.
4) Wolk MJ, Bailey SR, Doherty JU, et al:ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 63:380-406, 2014.

II 実践編 非侵襲的虚血評価をどう使い分けるか

P.170 掲載の参考文献
1) Diamond GA, Forrester JS:Analysis of probability as an aid in the clinical diagnosis of coronaryartery disease. N Engl J Med 300:1350-1358, 1979.
2) Knuuti J, Wijns W, Saraste A, et al:2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J, 2019.
3) Rozanski A, Gransar H, Hayes SW, et al:Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing:1991 to 2009. J Am Coll Cardiol 61:1054-1065, 2013.
4) Abidov A, Rozanski A, Hachamovitch R, et al:Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 353:1889-1898, 2005.
5) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
6) Myers J, Froelicher VF:Exercise testing. Procedures and implementation. Cardiol Clin 11:199-213, 1993.
7) Mark DB, Shaw L, Harrell FE, et al:Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325:849-853, 1991.
8) 日本循環器学会ほか:冠動脈病変の非侵襲的診断法に関するガイドライン. 2009. http://www.j-circ.or.jp/guideline/pdf/JCS2010_yamashina_h.pdf
9) Yuoness SA, Goha AM, Romsa JG, et al:Very high coronary artery calcium score with normal myocardial perfusion SPECT imaging is associated with a moderate incidence of severe coronary artery disease. Eur J Nucl Med Mol Imaging 42:1542-1550, 2015.
10) Noguchi T, Kawasaki T, Tanaka A, et al:High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol 63:989-999, 2014.
11) Otsuka K, Fukuda S, Tanaka A, et al:Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging 6:448-457, 2013.
12) Puchner SB, Liu T, Mayrhofer T, et al:High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain:results from the ROMICAT-II trial. J Am Coll Cardiol 64:684-692, 2014.
13) Motoyama S, Kondo T, Sarai M, et al:Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 50:319-326, 2007.
15) Shaw LJ, Berman DS, Maron DJ, et al:Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden:results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283-1291, 2008.
16) Nanasato M, Matsumoto N, Nakajima K, et al:Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease:J-ACCESS 4 study. Int J Cardiol 267:202-207, 2018.
P.184 掲載の参考文献
1) Weiss AT, Berman DS, Lew AS, et al:Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy:A marker of severe and extensive coronary artery disease. J Am Coll Cardiol:752-759, 1987.
2) Aarnoudse WH, Botman KJ, Pijls NH:False-negative myocardial scintigraphy in balanced threevessel disease, revealed by coronary pressure measurement. Int J Cardiovasc Intervent 5:67-71, 2003.
3) Sasaki H, Shimizu M, Ogawa K, et al:Defect images in stress thallium-201 myocardial scintigraphy in patients with complete left bundle branch block:comparison of exercise stress and pharmacological stress. J Cardiol 49:179-185, 2007.
4) Watarida S, Onoe M, Sugita T, et al:Clinical significance of reverse redistribution phenomenon after coronary artery bypass grafting. Ann Thorac Surg Jun 59:1582-1532, 1995.
P.191 掲載の参考文献
1) Allman KC, Shaw LJ, Hachamovitch R, Udelson JE:Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis. J Am Coll Cardiol 39:1151-1158, 2002.
2) Dilsizian V, Bonow RO:Current diagnostic techniques for assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87:1-20, 1993.
3) Bonow RO, Dilsizian V:Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. J Nucl Med 33:815-818, 1992.
4) Mori T, Minamiji K, Kurogane H, et al:Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 32:1718-1724, 1991.
5) Ohtani H, Tamaki N, Yonekura Y, et al:Value of thallium-201 rein- jection after delayed SPECT imaging for predicting reversible isch- emia after coronary artery bypass grafting. Am J Cardiol 66:394-399, 1990.
6) Bax JJ, Poldermans D, Elhendy A, et al:Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26:147-186, 2001.
P.199 掲載の参考文献
2) Burrell S, MacDonald A:Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol 34:193-211;quiz 212-194, 2006.
3) Hansen CL:The conundrum of left bundle branch block. J Nucl Cardiol 11:90-92, 2004.
4) Ten Cate TJ, Kelder JC, Bogaard MD, et al:The prognostic significance of typical perfusion defects on vasodilator stress myocardial perfusion SPECT in patients with left bundle branch block or right ventricular apical pacing. Nucl Med Commun 30:232-239, 2009.
5) Das KJ, Patel CD, Sharma G, et al:Detection of perfusion abnormalities in patients with permanent pacemakers on stress-rest 99mTc-tetrofosmin myocardial perfusion single-photon emission computed tomography:comparison between right ventricular apex and right ventricular outflow tract pacing. Nucl Med Commun 37:406-411, 2016.
6) Burns RJ, Galligan L, Wright LM, et al:Improved specificity of myocardial thallium-201 singlephoton emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol 68:504-508, 1991.
7) Nichols K, Dorbala S, DePuey EG, et al:Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification. J Nucl Med 40:924-934, 1999.
8) Taki J, Higuchi T, Nakajima K, et al:Electrocardiographic gated (99m) Tc-MIBI SPECT for functional assessment of patients after coronary artery bypass surgery:comparison of wall thickening and wall motion analysis. Journal of nuclear medicine:official publication, Society of Nuclear Medicine 43:589-595, 2002.
9) Reynolds HR, Tunick PA, Grossi EA, et al:Paradoxical septal motion after cardiac surgery:a review of 3,292 cases. Clinical cardiology 30:621-623, 2007.
P.201 掲載の参考文献
1) Agatston AS, Janowitz WR, Hildner FJ, et al:Quantification of Coronary-Artery Calcium Using Ultrafast Computed-Tomography. J Am Coll Cardiol 15:827-832, 1990.
2) Hecht HS, Cronin P, Blaha MJ, et al:2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans:A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Cardiovasc Comput Tomogr 11:74-84, 2017.
3) Budoff MJ, Shaw LJ, Liu ST, et al:Long-term prognosis associated with coronary calcification:observations from a registry of 25,253 patients. J Am Coll Cardiol 49:1860-1870, 2007.
4) Berman DS, Wong ND, Gransar H, et al:Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 44:923-930, 2004.
P.212 掲載の参考文献
1) Kawai Y, Morita K:Diagnostic value of 123I-betamethyl-p-iodophenyl-pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) in patients with chest pain. Circ J 68:547-552, 2004.
2) Morita K, Tsukamoto E. Tamaki N, et al:Perfusion-BMIPP mismatch:specific finding or artifact, Int J Card Imaging 1:61-69, 1999.
3) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
4) Moroi M, Tamaki N, Nishimura M, et al:Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis:results from a cohort study in Japan. Am J Kidney Dis 61:466-475, 2013.
5) Nakata T, Hashimoto A, Moroi M, et al:Sudden death prediction by C-reactive protein, electrocardiographic findings, and myocardial fatty acid uptake in haemodialysis patients:analysis of a multicentre prospective cohort sub-study. Eur Heart J Cardiovasc Imaging 17:1394-1404, 2016.
P.215 掲載の参考文献
1) Serruys PW, Morice MC, Kappetein AP, et al:Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961-972, 2009.
2) Tonino PA, De Bruyne B, Pijls NH, et al:Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213-224, 2009.
P.220 掲載の参考文献
1) Hachamovitch R, Hayes SW, Friedman JD, et al:Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography. Circulation 107:2900-2907, 2003.
2) Nishimura T, Nakajima K, Kusuoka H, et al:Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT:J-ACCESS study Eur J Nucl Med Mol Imaging 35:319-328, 2008.
3) Nakajima K, Matsuo S, Wakabayashi H, et al:Diagnostic Performance of Artificial Neural Network for Detecting Ischemia in Myocardial Perfusion Imaging. Circ J 79:1549-1556, 2015.
P.227 掲載の参考文献
1) Myers J, Froelicher VF:Exercise testing. Procedures and implementation. Cardiol Clin 11:199-213, 1993.
2) Wolk MJ, Bailey SR, Doherty JU, et al:ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. J Am Coll Cardiol 63:380-406, 2014.
3) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
4) Christman MP, Bittencourt MS, Hulten E, et al:Yield of downstream tests after exercise treadmill testing:a prospective cohort study. J Am Coll Cardiol 63:1264-1274, 2014.
5) Budoff MJ, Raggi P, Beller GA, et al:Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient. JACC Cardiovasc Imaging 9:176-192, 2016.
P.232 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) Knuuti J, Wijns W, Saraste A, et al:2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J:2019.
3) Mark DB, Shaw L, Harrell FE, et al:Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325:849-853, 1991.
4) Bourque JM, Holland BH, Watson DD, Beller GA:Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia:does myocardial perfusion imaging have a role? J Am Coll Cardiol 54:538-545, 2009.
5) Smith L, Myc L, Watson D, et al:A high exercise workload of >- 10 METS predicts a low risk of significant ischemia and cardiac events in older adults. J Nucl Cardiol:2018.
P.238 掲載の参考文献
1) Pellikka PA, Nagueh SF, Elhendy AA, et al:American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021-1041, 2007.
2) Lancellotti P, Pellikka PA, Budts W, et al:The clinical use of stress echocardiography in nonischaemic heart disease:recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Img 17:1191-1229, 2016.
3) 日本心エコー図学会:負荷心エコー図検査実施のための手引き. http://www.jse.gr.jp/contents/guideline/data/stressecho.pdf
4) 日本循環器学会ほか:非心臓手術における合併心疾患の評価と管理に関するガイドライン(2014改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2014_kyo_h.pdf
5) Das MK, Pellikka PA, Mahoney DW, et al:Assessment of cardiac risk before nonvascular surgery. J Am Coll Cardiol 35:1647-1653, 2000.
P.244 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) 日本循環器学会ほか:循環器超音波検査の適応と判読ガイドライン(2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010yoshida.h.pdf
3) Knuuti J, Wijns W, Saraste A, et al:2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 0:1-71, 2019.
4) Plonska-Gosciniak E, Kukulski T, Kasprzak J, et al:Stress echocardiography. Part II:J Ultrason 19:49-53, 2019.
5) Plonska-Gosciniak E, Gackowski A, Kukulski T, et al:Stress echocardiography. Part I:Stress echocardiography in coronary heart disease. J Ultrason 19:45-48, 2019.
6) Mahajan N, Polavaram L, Vankayala H, et al:Diagnostic accuracy of myocardial perfusion imaging and stress echocardiography for the diagnosis of left main and triple vessel coronary artery disease:a comparative meta-analysis. Heart 96:956-966, 2010.
7) Medical Advisory Secretariat:Stress echocardiography for the diagnosis of coronary artery disease:an evidence-based analysis. Ont Health Technol Assess Ser 10:1-61, 2010.
8) Pellikka PA, Nagueh SE, Elhendy AA, et al:American Society of Echocardiography:American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021-1041, 2007.
9) 坂田好美:どう行う? ドブタミン負荷心エコー法 虚血性心疾患に対する負荷心エコー法. 心エコー 16:676-684, 2015.
10) Sicari R, Cortigiani L:The clinical use of stress echocardiography in ischemic heart disease. Cardiovasc Ultrasound 15:7, 2017.
11) Lang RM, Badano LP, Mor-Avi V, et al:Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39, 2015.
12) Geleijnse ML, Fioretti PM, Roelandt JR:Methodology, feasibility, safety and diagnostic accuracy of dubutamine stress echocardiography. J Am Coll Cardiol 30:595-606, 1997.
13) Armstrong WF, Ryan T:Stress echocardiography from 1979 to present. J Am Soc Echocardiogr 21:22-28, 2008.
14) Marwick TH:Stress echocardiography. Heart 89:113-118, 2003.
P.247 掲載の参考文献
1) Pellikka PA, Nagueh SF, Elhendy AA, et al:American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021-1041, 2007.
2) Lang, RM, Badano LP, Mor-Avi V, et al:Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults:An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39, e14, 2015.
P.255 掲載の参考文献
1) Pellikka PA, Nagueh SF, Elhendy AA, et al:American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021-1041, 2007.
2) Sicari R, Nihoyannopoulos P, Evangelista A, et al:Stress echocardiography expert consensus statement:European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 9:415-437, 2008.
3) Bax JJ, Poldermans D, Elhendy A, et al:Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26:147-186, 2001.
4) Tani T, Teragaki M, Watanabe H, et al:Detecting viable myocardium and predicting functional improvement:comparisons of positron emission tomography, rest-redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography. Circ J 68:950-957, 2004.
5) Sawada S, Bapat A, Vaz D, et al:Incremental value of myocardial viability for prediction of longterm prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 42:2099-2105, 2003.
P.258 掲載の参考文献
1) Lancellotti P, Pellikka PA, Budts WC, et al:The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease:Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 30:101-138, 2017.
2) Nishimura RA, Otto CM, Bonow RO, et al:2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:2440-2492, 2014.
3) Monin JL, Quere JP, Monchi M, et al:Low-gradient aortic stenosis:operative risk stratification and predictors for long-term outcome:a multicenter study using dobutamine stress hemodynamics. Circulation 108:319-324, 2003.
4) Ribeiro HB, Lerakis S, Gilard M:Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis:The TOPAS-TAVI Registry. J Am Coll Cardiol 71:1297-1308, 2018.
5) Suzuki T, Izumo M, Suzuki K, et al:Prognostic value of exercise stress echocardiography in patients with secondary mitral regurgitation:a long-term follow-up study. J Echocardiogr 17:147-156, 2019.
6) Stone GW, Lindenfeld J, Abraham WT, et al:Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 379:2307-2318, 2018.
P.264 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
2) Sheth T, Dodd JD, Hoffmann U, et al:Coronary stent assessability by 64 slice multi-detector computed tomography. Catheter Cardiovasc Interv 69:933-938, 2007.
3) Chan M, Ridley L, Dunn DJ, et al:A systematic review and meta-analysis of multidetector computed tomography in the assessment of coronary artery bypass grafts. Int J Cardiol 221:898-905, 2016.
4) Motoyama S, Sarai M, Harigaya H, et al:Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54:49-57, 2009.
5) Cury RC, Abbara S, Achenbach S, et al:CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10:269-281, 2016.
6) Gottlieb I, Miller JM, Arbab-Zadeh A, et al:The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 55:627-634, 2010.
P.273 掲載の参考文献
1) Abbara S, Arbab-Zadeh A, Callister TQ, et al:SCCT guidelines for performance of coronary computed tomographic angiography:A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 3:190-204, 2009.
2) 佐野始也:基礎講座 -心臓病(特に虚血性心疾患)の診断から治療まで- 6. 虚血性心疾患の診断 (4) X線CT検査. 日放技誌 69:1444-1454, 2013.
3) Sano T, Kondo T, Matsutani H, et al:Significance of PQ interval in acquisition of coronary multidetector row computed tomography. J Cardiology 54:441-451, 2009.
4) 関根貴子, 児玉隆秀, 近藤武, ほか:冠動脈MDCT撮影におけるプロプラノロール静注の有用性と安全性. 日放技誌 66:1539-1547, 2010.
5) 立木秀一, 近藤武, 天沼誠, ほか:Agatston Scoreを用いた日本人における閉塞性冠動脈疾患の有病率の推定. 心臓 48:1020-2032, 2016.
6) Amanuma M, Kondo T, Arai T, et al:Segmental distributions of calcifications and non- assessable lesions on coronary computed tomographic angiography:Evaluation in symptomatic patients. Jpn J Radiol 33:122-130, 2015.
7) Weigold WG, Abbara S, Achenbach S, et al:Standardized medical terminology for cardiac computed tomography:a report of the Society of Cardiovascular Computed Tomography. Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr 5:136-144, 2011.
8) Amanuma M, Kondo T, Sano T, et al:Subtraction coronary computed tomography in patients with severe calcification. Int J Cardiovasc Imaging 31:1635-1642, 2015.
9) Patel MR, Norgaard BL, Fairbairn TA, et al:1-Year Impact on Medical Practice and Clinical Outcomes of FFR-CT:The ADVANCE Registry. JACC Cardiovasc Imaging 17:pii:S1936-878X(19)30227-X, 2019.
10) Imai S, Kondo T, Stone GW, et al:Abnormal Fractional Flow Reserve in Nonobstructive Coronary Artery Disease. Circ Cardiovasc Interv 12:e006961, 2019.
11) Knuuti J, Wijns W, Saraste A, et al:2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 31:pii:ehz425, 2019.
12) Pouleur AC, le Polain de Waroux JB, Kefer J, et al:Direct comparison of whole-heart navigatorgated magnetic resonance coronary angiography and 40- and 64-slice multidetector row computed tomography to detect the coronary artery stenosis in patients scheduled for conventional coronary angiography. Circ Cardiovasc Imaging 1:114-121, 2008.
P.279 掲載の参考文献
1) Schindler TH, Magosaki N, Jeserich M, et al:Fusion imaging:combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease. Int J Card Imaging 15:357-68;discussion 369-370, 1999.
2) Gaemperli O, Schepis T, Kalff V, et al:Validation of a new cardiac image fusion software for threedimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging 34:1097-1106, 2007.
3) Gaemperli O, Schepis T, Valenta I, et al:Cardiac image fusion from stand-alone SPECT and CT:clinical experience. J Nucl Med 48:696-703, 2007.
4) Rispler S, Keidar Z, Ghersin E, et al:Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol 49:1059-1067, 2007.
5) 後藤義崇, 川崎友裕 福山尚哉:心筋Single Photon Emission Tomography(SPECT)心臓Computed Tomography(CT)を用いたFusion画像による虚血性心疾患診断の有用性. 日本心臓病学会誌 6:19-25, 2011.

III 症例解説 知っておきたい まれな症例

P.295 掲載の参考文献
1) Taqueti VR, Hachamovitch R, Murthy VL, et al:Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131:19-27, 2015.
P.299 掲載の参考文献
1) Bech GD, De Bruyne B, Pijls NH, et al:Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis:a randomized trial. Circulation 103:2928-2934, 2001.
2) Tonino PA, De Bruyne B, Pijls NH, et al:Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213-224, 2009.
P.303 掲載の参考文献
1) Taki J, Ichikawa A, Nakajima K, et al:Comparison of flow capacities of arterial and venous grafts for coronary artery bypass grafting:evaluation with exercise thallium-201 single-photon emission tomography. Eur J Nucl Med 24:1487-1493, 1997.
P.311 掲載の参考文献
1) Sadaniantz A, Katz A, Wu WC:Miscellaneous use of exercise echocardiography in patients with chronic pulmonary disease or congenital heart defect. Echocardiography 21:477-484, 2004.
2) Lancellotti P, Pellikka PA, Budts W, et al:The clinical use of stress echocardiography in nonischaemic heart disease:recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 17:1191-1229, 2016.

IV ガイドライン概説

P.322 掲載の参考文献
1) 日本循環器学会ほか:慢性冠動脈疾患診断ガイドライン(2018年改訂版). 2019. http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf
3) Montalescot G, Sechtem U, Achenbach S:2013 ESC guidelines on the management of stable coronary artery disease:the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949-3003, 2013.
4) 真玉英生, 安田聰:慢性冠動脈疾患診断ガイドライン(2018年改訂版)について -外部評価委員の立場から-. Prog Med 39:595-600, 2019.

最近チェックした商品履歴

Loading...